Respiratory Syncytial Virus (RSV) Neutralizing Antibodies at Birth Predict Protection from RSV Illness in Infants in the First 3 Months of Life.
Andrea G BuchwaldBarney S GrahamAwa TraoreFadima Cheick HaidaraMan ChenKaitlyn MorabitoBob C LinSamba O SowMyron M LevineMarcela F PasettiMilagritos D TapiaPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)
Maternally acquired RSV antibodies were associated with protection of infants against community-detected cases of RSV-ILI and pneumonia. RSV titers in cord blood can predict whether an infant will be infected with RSV or remain uninfected.